Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04917068 · ClinicalTrials.gov registry record
Neurobiological and Psychological Maintenance Mechanisms Associated With Anticipatory Reward in Bulimia Nervosa
A clinical trial of Bulimia Nervosa, sponsored by University of Minnesota.
- Recruiting
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT04917068: Recruiting study of Bulimia Nervosa, sponsored by University of Minnesota.
NCT04917068 is a study of Bulimia Nervosa that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 100 participants, below the 1,734-participant average among 23 other Bulimia Nervosa trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04917068, a study of Bulimia Nervosa, is actively recruiting participants, sponsored by University of Minnesota.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this investigation is to identify the potentially crucial role of anticipatory reward mechanisms maintaining bulimic behavior (i.e., binge eating and purging) in bulimia nervosa (BN). The research will investigate neural and psychological anticipatory processes in BN, both in the scanner and the natural environment.
Primary Outcome
The Positive and Negative Affect Schedule (PANAS) is a self-report measure comprising two scales, one of which we will use to assess participants' negative affect. The scale includes ten Likert-style items, which participants rate from 1 = not at all to 5 = very much. Composite scores range from 10-50, and a score of 50 indicates greater negative affect. The PANAS will be administered to measure emotion at multiple times during the second visit as well as during EMA administration and to establi
Conditions Studied
Study Locations (1)
Minnesota
- University of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2022-04-01 |
| Est. Completion | 2026-11-30 |
What NCT04917068 shows while recruiting
NCT04917068 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,734-participant average among 23 other Bulimia Nervosa trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Bulimia Nervosa appearing as the primary indexed condition, and to 0 interventions.
NCT04917068 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT04917068 about?
NCT04917068 is a clinical study titled "Neurobiological and Psychological Maintenance Mechanisms Associated With Anticipatory Reward in Bulimia Nervosa". The purpose of this investigation is to identify the potentially crucial role of anticipatory reward mechanisms maintaining bulimic behavior (i.e., binge eating and purging) in bulimia nervosa (BN). The research will investigate neural and psychological anticipatory processes in BN, both in the scan...
What is the current status of trial NCT04917068?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2022-04-01. Estimated completion is 2026-11-30.
What conditions does trial NCT04917068 study?
This clinical trial studies the following conditions: Bulimia Nervosa.
Who is sponsoring clinical trial NCT04917068?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04917068 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bulimia Nervosa
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04917068's enrollment target sits among peer trials
100 8th of 23 higher than 16 of 23 other Bulimia Nervosa trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Bulimia Nervosa trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Therapeutic Ketogenic Diet in Anorexia Nervosa
RECRUITING · NA
-
Changes in Inhibition and Valuation After Eating
RECRUITING · NA
-
Eating Disorders Genetics Initiative 2
RECRUITING
-
Incentive Processing and Learning in Anorexia Nervosa and Bulimia Nervosa
RECRUITING
-
Targeting Social Function in Anxiety and Eating Disorders
RECRUITING · NA
-
Developing an Artificial Intelligence (AI) Chatbot for Adolescents and Young Adults With Eating Disorders
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI